Small Molecules

23 Aug 2018 European Commission grants marketing authorization for Lenvima (lenvatinib) as first-line treatment in adults with advanced or unresectable hepatocellular carcinoma
22 Aug 2018 Mallinckrodt Confirms Receipt of Stannsoporfin Complete Response Letter
22 Aug 2018 AbbVie Announces Positive Topline Results from Phase 3 Extension Study Evaluating Investigational Elagolix in Women with Uterine Fibroids
22 Aug 2018 Allergan Receives Complete Response Letter from the U.S. Food and Drug Administration for Ulipristal Acetate New Drug Application
21 Aug 2018 Can-Fite Announces Enrollment of First Patient in its Comfort™ Phase III Trial of Piclidenoson in Psoriasis
21 Aug 2018 Imago BioSciences Completes Enrollment in Phase 1/2a Study of IMG-7289 in Acute Myeloid Leukemia and Myelodysplastic Syndrome
21 Aug 2018 Rexahn Pharmaceuticals Announces Clinical Collaboration with Merck to Evaluate RX-5902 (Supinoxin™) in combination with KEYTRUDA® (pembrolizumab) for Triple Negative Breast Cancer
21 Aug 2018 MC2 Therapeutics Announces Positive Top-line Results from Phase 3 Clinical Trial Comparing MC2-01 Cream to Taclonex® in Adults with Psoriasis
20 Aug 2018 Kyowa Hakko Kirin Announces Results of Early Phase 2 Trial of KW-6356 for Parkinson's Disease at IAPRD
20 Aug 2018 Fractionated Dosing Improves Tolerability and Safety of Cellectar’s CLR 131 in R/R Multiple Myeloma Patients
20 Aug 2018 Sensorion Receives European Authorization to Initiate SENS-401 Phase 2 Trial in Sudden Sensorineural Hearing Loss
18 Aug 2018 Tolero Pharmaceuticals Announces Clinical Research Collaboration with AbbVie for Acute Myeloid Leukemia Trial
18 Aug 2018 Mateon Therapeutics Receives Notice of Partial Clinical Hold for OX1222 Study
17 Aug 2018 Eisai and Merck Announce FDA Approval of LENVIMA® (lenvatinib) Capsules for First-line Treatment of Unresectable Hepatocellular Carcinoma (HCC)
16 Aug 2018 Biohaven Reports Positive Results From Double-Blind, Placebo-Controlled, Investigator Initiated, Proof Of Concept Trial Of BHV-0223 For Anxiety
16 Aug 2018 Sun Pharma Announces U.S. FDA Approval of CEQUA™ to Treat Dry Eye Disease
16 Aug 2018 FDA Approves KALYDECO® (ivacaftor) as First and Only Medicine to Treat the Underlying Cause of CF in Children Ages 12 to less than 24 Months with Certain Mutations in the CFTR Gene
15 Aug 2018 Leadiant Biosciences to Collaborate with National Institutes of Health on Therapy in Late-Stage Development for GNE Myopathy
15 Aug 2018 ViiV Healthcare reports positive 48-week results for first pivotal, phase III study for novel, long-acting, injectable HIV-treatment regimen
14 Aug 2018 Entasis Therapeutics Announces Positive Topline Results from Phase 2 Trial of ETX2514SUL in Patients with Complicated Urinary Tract Infections including Acute Pyelonephritis
14 Aug 2018 Realm Therapeutics Reports Top-line Data from Phase 2 Trial of PR022 in Atopic Dermatitis and First Half 2018 Financial Results
14 Aug 2018 TLC Doses First Patients in Phase I/II Trial of TLC590 for Postsurgical Pain Management
13 Aug 2018 FDA Accepts New Drug Application (NDA) to review Midazolam Nasal Spray, an investigational product for the acute treatment of seizure clusters
11 Aug 2018 Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD
11 Aug 2018 Orphazyme announces enrollment of first patient in Phase III clinical trial of arimoclomol for ALS

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up